Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Pyelonephritis - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report delivers a detailed overview of the current ...

Extended-spectrum beta-lactamases (ESBLs) are enzymes or chemicals produced by germs like certain bacteria. These enzymes make bacterial infections harder to treat with antibiotics. Here's what you ...

Background. Escherichia coli-bearing Dr-adhesins (Dr+ E. coli) cause chronic pyelonephritis in pregnant women and animal models. This chronic renal infection correlates with the capacity of bacteria ...

Tebipenem pivoxil hydrobromide is an orally bioavailable carbapenem with activity against uropathogenic Enterobacterales. Oral tebipenem pivoxil hydrobromide (HBr), a carbapenem, is as effective as ...

This is a preview. Log in through your library . Abstract P-fimbrial genotypes of Escherichia coli strains and their possible association with urinary tract abnormalities were studied in infants with ...

Scientists from DTU have discovered that a combination of two common antibiotics can eliminate multi-drug resistant E. coli causing urinary tract infections; this combination treatment could become an ...

The ability of bacteria and microbial pathogens to become resistant to the antimicrobial treatments intended to kill them is a global issue, identified by the World Health Organisation (WHO) as one of ...

(MENAFN- GlobeNewsWire - Nasdaq) The market for pyelonephritis treatments presents opportunities in novel drug development, emphasizing advanced ESBL coverage and efficacy under acidic conditions. Key ...